Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

uMotif Completes Record Growth Year; Advances Modern eCOA/ePRO Tech; Wins Awards for Validated Patient Data Capture App, CEO Leadership; Signs Strategic Partners in 2023


News provided by

uMotif

Jan 22, 2024, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Modern, patient-centric eCOA/ePRO for clinical trials and real-world studies
Modern, patient-centric eCOA/ePRO for clinical trials and real-world studies

Consistently enhances eCOA/ePRO platform for sponsors, sites and patients; earns Best of Show from SCOPE Summit attendees for Motif patient data capture app; second PharmaVOICE 100 award for CEO Steve Rosenberg; signs partnerships with Syneos Health, Cogstate, ActiGraph, Veramed; will demonstrate innovations at SCOPE 2024

BOSTON and LONDON, Jan. 22, 2024 /PRNewswire-PRWeb/ -- uMotif – one of the clinical research technology market's fastest-growing companies – continues to move the industry forward with innovations to its modern, patient-centric eCOA/ePRO platform powering clinical trials and real-world studies for an expanding, global customer base.

Key uMotif 2023 achievements include…

"By giving sponsors and CROs a modern, user-friendly eCOA/ePRO solution that puts the needs of patients first, we ensure that customers can capture the large volumes of data necessary to maximize the success of a clinical trial." --uMotif CEO Steve Rosenberg

Post this

eCOA/ePRO and Patient Data Capture Enhancements

uMotif built on its track record of delivering patient-centric eCOA/ePRO with enhancements to its feature-rich platform, built with and for patients to achieve unprecedented levels of compliance. Enriched capabilities include an adaptive scheduling and questionnaire engine, a comprehensive patient engagement toolkit, and advanced analytics and custom reporting.

Industry Partnerships

uMotif and Syneos Health, a leading, fully integrated biopharmaceutical solutions organization, announced a partnership to deliver a patient-centric, eClinical platform to accelerate clinical trials and bring new therapies to patients faster. In addition to uMotif providing eCOA/ePRO services for Syneos Health customers, the companies are developing an exclusive patient-centric platform to deliver seamless, integrated customer solutions including patient identification, recruitment, eConsent, eDiary, patient engagement and retention, and payments.

uMotif and Cogstate Limited (ASX:CGS) are bringing research sponsors and CROs the combined power of uMotif's cloud-based, patient-centric eCOA/ePRO and Cogstate's market-leading cognitive testing services. The companies are building on their existing work together – including a major Phase 2 trial of a psychedelic therapeutic – to significantly improve patient engagement and data quality in all therapeutic areas, and especially in CNS research. As part of uMotif's integrated eCOA solutions, the cloud-based system also supports a wide range of Clinician Reported Outcomes (ClinROs), including those requiring audio recording of assessments for central review and scoring.

uMotif was invited by ActiGraph, a leading provider of remote monitoring technology, to join its Accelerant™ Partner Program based on uMotif's unique focus on the patient experience. Together the companies are delivering a seamless, patient-centered solution for clinical research that combines modern eCOA/ePRO and best-in-class wearable devices to help sponsors and CROs capture massive volumes of high-quality data by truly understanding how to engage patients.

uMotif and advanced biostatistics consultancy Veramed teamed to redefine how eCOA/ePRO data is collected, reported, visualized, and analyzed. Together the companies generate high-quality, actionable insights to drive quantifiable improvements in clinical research by offering sponsors the unique advantages of the industry's most advanced data analysis and visualization support on top of uMotif's eCOA/ePRO platform, as seen in the groundbreaking "100 for Parkinson's" study.

Industry Recognition

SCOPE Summit Best of Show – Attendees awarded the patented Motif data capture app for its ability to engage patients in clinical trials and real-world studies. SAFIRA Clinical Research independently validated the Motif as the first new data capture innovation since paper instruments on smartphones – eliminating reliance on text-based instruments.

PharmaVoice 100 – CEO Steve Rosenberg was named to the list of the most influential and inspiring people in life sciences for the second time, for his vision and pragmatism in commercializing transformative technologies to accelerate clinical research for sponsors, sites and patients.

Steve Rosenberg said: "uMotif is well-positioned to continue gaining momentum in 2024. Over the past year, we've demonstrated why our eCOA/ePRO platform is the most modern solution on the market today, achieving high levels of engagement by guiding the patient through the trial. By giving sponsors and CROs a user-friendly eCOA/ePRO solution that puts the needs of patients first, we ensure that customers can capture the large volumes of data necessary to maximize the success of a clinical trial."

Meet the uMotif team at SCOPE Summit 2024, Booth 731 to discuss how we can help your organization improve its clinical research programs.

About uMotif

Putting patients first is in uMotif's DNA. The uMotif eCOA/ePRO platform delivers faster, quality clinical trials and real-world studies by putting patients at the core of research. Through cloud-hosting in the US, Europe and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports any study or trial, from Clinical Phase I, II and III studies through to decentralized or virtual real-world studies. Find out how uMotif can improve your clinical research programs and real-world studies at www.umotif.com

Media Contact

Brenda Nashawaty, uMotif, 1 6176883253, [email protected], www.umotif.com

Elaine Maynard, uMotif, 1 6176883253, [email protected], www.umotif.com 

SOURCE uMotif

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.